Advanced Cancer: TH9619 Treatment Study

We are evaluating the safety and potential anticancer effects of a new drug, TH9619, in patients with advanced cancer. This study aims to understand how different doses may work in treating this condition.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Gustave Roussy
GI Oncology
Villejuif, France
Vall D Hebron Institute Of Oncology
Medical Oncology
Alboraya, Spain
Hospital Universitario Fundacion Jimenez Diaz
Oncology
Madrid, Spain
Sponsor: One-carbon Therapeutics AB
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.